|
1.
|
Bonventre JV and Zuk A: Ischemic acute
renal failure: an inflammatory disease? Kidney Int. 66:480–485.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
2.
|
Thurman JM: Triggers of inflammation after
renal ischemia/reperfusion. Clin Immunol. 123:7–13. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
3.
|
Ysebaert DK, De Greef KE, De Beuf A, et
al: T cells as mediators in renal ischemia/reperfusion injury.
Kidney Int. 66:491–496. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
4.
|
Erdogan H, Fadillioglu E, Yagmurca M, Ucar
M and Irmak MK: Protein oxidation and lipid peroxidation after
renal ischemia-reperfusion injury: protective effects of erdosteine
and N-acetylcysteine. Urol Res. 34:41–46. 2006. View Article : Google Scholar
|
|
5.
|
Li XL, Zou XM, Gao P, Li YL, Wang H and
Chen XW: Role of nitric oxide in ischemia-reperfusion injury and
acute rejection in rat intestinal transplantation. Transplant Proc.
40:3342–3345. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
6.
|
Xia Z, Godin DV, Chang TK and Ansley DM:
Dose-dependent protection of cardiac function by propofol during
ischemia and early reperfusion in rats: effects on
15-F2t-isoprostane formation. Can J Physiol Pharmacol. 81:14–21.
2003. View
Article : Google Scholar : PubMed/NCBI
|
|
7.
|
Javadov SA, Lim KH, Kerr PM, Suleiman MS,
Angelini GD and Halestrap AP: Protection of hearts from reperfusion
injury by propofol is associated with inhibition of the
mitochondrial permeability transition. Cardiovasc Res. 45:360–369.
2000. View Article : Google Scholar : PubMed/NCBI
|
|
8.
|
Kokita N, Hara A, Abiko Y, Arakawa J,
Hashizume H and Namiki A: Propofol improves functional and
metabolic recovery in ischemic reperfused isolated rat hearts.
Anesth Analg. 86:252–258. 1998.PubMed/NCBI
|
|
9.
|
Yang CY, Wong CS, Yu CC, Luk HN and Lin
CI: Propofol inhibits cardiac L-type calcium current in guinea pig
ventricular myocytes. Anesthesiology. 84:626–635. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
10.
|
Zhou W, Fontenot HJ, Liu S and Kennedy RH:
Modulation of cardiac calcium channels by propofol. Anesthesiology.
86:670–675. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
11.
|
Jordan JE, Zhao ZQ and Vinten-Johansen J:
The role of neutrophils in myocardial ischemia-reperfusion injury.
Cardiovasc Res. 43:860–878. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
12.
|
Simpson PJ, Fantone JC, Mickelson JK,
Gallagher KP and Lucchesi BR: Identification of a time window for
therapy to reduce experimental canine myocardial injury:
suppression of neutrophil activation during 72 hours of
reperfusion. Circ Res. 63:1070–1079. 1988. View Article : Google Scholar
|
|
13.
|
Shin IW, Lim BW, Chung YS, et al: The
effect of propofol on myocardial protection after regional
ischemia-reperfusion injury in an in vivo rat heart model. Korean J
Anesthesiol. 55:338–343. 2008. View Article : Google Scholar
|
|
14.
|
Nauth A, Ristiniemi J, McKee MD and
Schemitsch EH: Bone morphogenetic proteins in open fractures: past,
present, and future. Injury. 40(Suppl 3): S27–S31. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
15.
|
El-Bizri N, Guignabert C, Wang L, et al:
SM22alpha-targeted deletion of bone morphogenetic protein receptor
1A in mice impairs cardiac and vascular development, and influences
organogenesis. Development. 135:2981–2991. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
16.
|
Hansmann G, de Jesus Perez VA, Alastalo
TP, et al: An antiproliferative BMP-2/PPARgamma/apoE axis in human
and murine SMCs and its role in pulmonary hypertension. J Clin
Invest. 118:1846–1857. 2008. View
Article : Google Scholar : PubMed/NCBI
|
|
17.
|
Wybenga DR, Di Giorgio J and Pileggi VJ:
Manual and automated methods for urea nitrogen measurement in whole
serum. Clin Chem. 17:891–895. 1971.PubMed/NCBI
|
|
18.
|
Kueltzo LA, Ersoy B, Ralston JP and
Middaugh CR: Derivative absorbance spectroscopy and protein phase
diagrams as tools for comprehensive protein characterization: a
bGCSF case study. J Pharm Sci. 92:1805–1820. 2003. View Article : Google Scholar
|
|
19.
|
Paller MS, Hoidal JR and Ferris TF: Oxygen
free radicals in ischemic acute renal failure in the rat. J Clin
Invest. 74:1156–1164. 1984. View Article : Google Scholar : PubMed/NCBI
|
|
20.
|
Morsy MD, Mostafa OA and Hassan WN: A
potential protective effect of alpha-tocopherol on vascular
complication in spinal cord reperfusion injury in rats. J Biomed
Sci. 17:552010. View Article : Google Scholar : PubMed/NCBI
|
|
21.
|
Sasaki M and Joh T: Oxidative stress and
ischemia-reperfusion injury in gastrointestinal tract and
antioxidant, protective agents. J Clin Biochem Nutr. 40:1–12. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
22.
|
van der Heijden M, Versteilen AM, Sipkema
P, van Nieuw Amerongen GP, Musters RJ and Groeneveld AB:
Rho-kinase-dependent F-actin rearrangement is involved in the
inhibition of PI3-kinase/Akt during ischemia-reperfusion-induced
endothelial cell apoptosis. Apoptosis. 13:404–412. 2008.
|
|
23.
|
Bayrak O, Turgut F, Karatas OF, et al:
Oral beta-glucan protects kidney against ischemia/reperfusion
injury in rats. Am J Nephrol. 28:190–196. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
24.
|
Schramm L, Weierich T, Heldbreder E,
Zimmermann J, Netzer KO and Wanner C: Endotoxin-induced acute renal
failure in rats: effects of L-arginine and nitric oxide synthase
inhibition on renal function. J Nephrol. 18:374–381.
2005.PubMed/NCBI
|
|
25.
|
Spek CA, Brüggemann LW and Borensztajn KS:
Protease-activated receptor 2 blocking peptide counteracts
endotoxin-induced inflammation and coagulation and ameliorates
renal fibrin deposition in a rat model of acute renal failure.
Shock. 33:339author reply 339–340. 2010. View Article : Google Scholar
|
|
26.
|
Petronijević ND, Mićić DV, Duricić B,
Marinković D and Paunović VR: Substrate kinetics of erythrocyte
membrane Na, K-ATPase and lipid peroxides in schizophrenia. Prog
Neuropsychopharmacol Biol Psychiatry. 27:431–440. 2003.PubMed/NCBI
|
|
27.
|
Kato R and Foëx P: Myocardial protection
by anesthetic agents against ischemia-reperfusion injury: an update
for anesthesiologists. Can J Anaesth. 49:777–791. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
28.
|
Jin YC, Kim W, Ha YM, et al: Propofol
limits rat myocardial ischemia and reperfusion injury with an
associated reduction in apoptotic cell death in vivo. Vascul
Pharmacol. 50:71–77. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
29.
|
Sánchez-Conde P, Rodriguez-López JM,
Nicolás JL, et al: The comparative abilities of propofol and
sevoflurane to modulate inflammation and oxidative stress in the
kidney after aortic cross-clamping. Anesth Analg. 106:371–378.
2008.PubMed/NCBI
|
|
30.
|
Yuzbasioglu MF, Aykas A, Kurutas EB and
Sahinkanat T: Protective effects of propofol against
ischemia/reperfusion injury in rat kidneys. Ren Fail. 32:578–583.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
31.
|
Yuzer H, Yuzbasioglu MF, Ciralik H, et al:
Effects of intravenous anesthetics on renal ischemia/reperfusion
injury. Ren Fail. 31:290–296. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
32.
|
Dhore CR, Cleutjens JP, Lutgens E, et al:
Differential expression of bone matrix regulatory proteins in human
atherosclerotic plaques. Arterioscler Thromb Vasc Biol.
21:1998–2003. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
33.
|
Sorescu GP, Song H, Tressel SL, et al:
Bone morphogenic protein 4 produced in endothelial cells by
oscillatory shear stress induces monocyte adhesion by stimulating
reactive oxygen species production from a nox1-based NADPH oxidase.
Circ Res. 95:773–779. 2004. View Article : Google Scholar
|
|
34.
|
Shin V, Zebboudj AF and Boström K:
Endothelial cells modulate osteogenesis in calcifying vascular
cells. J Vasc Res. 41:193–201. 2004. View Article : Google Scholar
|
|
35.
|
Sorescu GP, Sykes M, Weiss D, et al: Bone
morphogenic protein 4 produced in endothelial cells by oscillatory
shear stress stimulates an inflammatory response. J Biol Chem.
278:31128–31135. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
36.
|
Abe J: Bone morphogenetic protein (BMP)
family, SMAD signaling and Id helix-loop-helix proteins in the
vasculature: the continuous mystery of BMPs pleiotropic effects. J
Mol Cell Cardiol. 41:4–7. 2006. View Article : Google Scholar
|
|
37.
|
Csiszar A, Lehoux S and Ungvari Z:
Hemodynamic forces, vascular oxidative stress, and regulation of
BMP-2/4 expression. Antioxid Redox Signal. 11:1683–1697. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
38.
|
Ten Dijke P, Goumans MJ, Itoh F and Itoh
S: Regulation of cell proliferation by Smad proteins. J Cell
Physiol. 191:1–16. 2002.PubMed/NCBI
|
|
39.
|
Funaki C, Hodges RR and Dartt DA: Role of
cAMP inhibition of p44/p42 mitogen-activated protein kinase in
potentiation of protein secretion in rat lacrimal gland. Am J
Physiol Cell Physiol. 293:C1551–C1560. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
40.
|
Csiszar A, Ahmad M, Smith KE, et al: Bone
morphogenetic protein-2 induces proinflammatory endothelial
phenotype. Am J Pathol. 168:629–638. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
41.
|
Csiszar A, Smith KE, Koller A, Kaley G,
Edwards JG and Ungvari Z: Regulation of bone morphogenetic
protein-2 expression in endothelial cells: role of nuclear
factor-kappaB activation by tumor necrosis factor-alpha,
H2O2, and high intravascular pressure.
Circulation. 111:2364–2372. 2005. View Article : Google Scholar
|
|
42.
|
Yang YL, Ju HZ, Liu SF, et al: BMP-2
suppresses renal interstitial fibrosis by regulating
epithelial-mesenchymal transition. J Cell Biochem. 112:2558–2565.
2011. View Article : Google Scholar : PubMed/NCBI
|
